期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
MicroRNA-125a-5p表达对弥漫大B细胞淋巴瘤耐药及临床预后的影响 被引量:6
1
作者 韩莹 杨文秀 +1 位作者 濮珍红 万珑 《中国现代医学杂志》 CAS 2018年第19期34-40,共7页
目的检测micro RNA-125a-5p(mi R-125a-5p)在弥漫性大B细胞淋巴瘤(DLBCL)组织中的表达情况,探讨其对肿瘤耐药及预后的影响。方法收集DLBCL石蜡标本及其临床病理资料并随访;采用实时荧光定量聚合酶链反应(q RT-PCR)检测组织中mi R-125a-5... 目的检测micro RNA-125a-5p(mi R-125a-5p)在弥漫性大B细胞淋巴瘤(DLBCL)组织中的表达情况,探讨其对肿瘤耐药及预后的影响。方法收集DLBCL石蜡标本及其临床病理资料并随访;采用实时荧光定量聚合酶链反应(q RT-PCR)检测组织中mi R-125a-5p的m RNA相对表达量;用免疫组织化学染色检测肿瘤组织中P糖蛋白(P-gp)、细胞增殖核抗原(Ki-67)蛋白的表达;分析mi R-125a-5p与耐药蛋白Pgp表达的关系,以及该表达对DLBCL肿瘤细胞增殖和临床病理特征及预后的影响。结果 Mi R-125a-5p在DLBCL组中的表达高于对照组,差异有统计学意义(P<0.05);其表达量与患者乳酸脱氢酶(LDH)、免疫表型相关(P<0.05),与年龄、性别、原发部位、临床分期、国际预后指数(IPI)均无相关(P>0.05);mi R-125a-5p高表达组P-gp蛋白阳性率高于低表达组;Kaplan-Meier及Log-rank生存分析显示低表达mi R-125a-5p患者的总生存期(OS)及无复发生存期(RFS)均高于高表达组,COX风险比例模型分析显示Ann Arbor分期Ⅲ、Ⅳ期及mi R-125a-5p高表达均可作为DLBCL患者预后不良的因素。结论 mi R-125a-5p与DLBCL耐药蛋白P-gp表达相关,mi R-125a-5p高表达及Ann Arbor分期Ⅲ、Ⅳ提示DLBCL患者预后较差,可作为潜在的DLBCL预后预测分子。 展开更多
关键词 大B细胞淋巴瘤 miR-125a-5p P-GP 实时荧光定量聚合酶链反应 预后
下载PDF
Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by Helicobacter pylori-induced activator protein-1 promotes gastric tumorigenesis via the PI3K/AKT/mTOR pathway 被引量:1
2
作者 Mei Luo Yuan-Jia Chen +6 位作者 Yuan Xie Qin-Rong Wang Yi-Ning Xiang Ni-Ya Long wen-xiu yang Yan Zhao Jian-Jiang Zhou 《World Journal of Gastroenterology》 SCIE CAS 2022年第47期6769-6787,共19页
BACKGROUND Gastric cancer(GC)is a common malignant tumor with high incidence and mortality rates globally,especially in East Asian countries.Helicobacter pylori(H.pylori)infection is a significant and independent risk... BACKGROUND Gastric cancer(GC)is a common malignant tumor with high incidence and mortality rates globally,especially in East Asian countries.Helicobacter pylori(H.pylori)infection is a significant and independent risk factor for GC.However,its underlying mechanism of action is not fully understood.Dickkopf-related protein(DKK)1 is a Wnt signaling antagonist,and cytoskeleton-associated protein(CKAP)4 is a newly identified DKK1 receptor.Recent studies found that the binding of DKK1 to CAKP4 mediated the procancer signaling of DKK1 independent of Wnt signaling.We hypothesize that H.pylori-induced activation of DKK1/CKAP4 signaling contributes to the initiation and progression of GC.AIM To investigate the interaction of H.pylori infection,DKK1 and CAKP4 in GC,as well as the underlying molecular mechanisms.METHODS RNA sequencing was used to identify differentially expressed genes(DEGs)between H.pylori-infected and uninfected primary GC cells.Gain-and loss-offunction experiments were performed to verify the H.pylori-induced upregulation of activator protein-1(AP-1)in GC cells.A dual-luciferase reporter assay and co-immunoprecipitation were used to determine the binding of AP-1 to the DKK1 promoter and DKK1 to CKAP4.Western blotting and immunohistochemistry detected the expression of DKK1,CKAP4,and phosphatidylinositol 3-kinase(PI3K)pathway-related proteins in GC cells and tissues.Functional experiments and tumorigenicity in nude mice detected malignant behavior of GC cells in vitro and in vivo.RESULTS We identified 32 DEGs between primary GC cells with and without H.pylori infection,including JUN,fos-like antigen-1(FOSL1),and DKK1,and confirmed that the three proteins and CKAP4 were highly expressed in H.pylori-infected GC cells,H.pylori-infected gerbil gastric tissues,and human GC tissues.JUN and FOSL1 form AP-1 to transcriptionally activate DKK1 expression by binding to the DKK1 promoter.Activated DKK1 bound to CKAP4,but not the most common Wnt coreceptor low-density lipoprotein receptor-related protein 5/6,to promote GC cell growth,colony formation,migration,invasion,and xenograft tumor growth in nude mice.All these effects were driven by activation of the PI3K/AKT/mammalian target of rapamycin(mTOR)pathway.Targeting the PI3K signaling pathway by LY294002 inhibited DKK1-mediated CKAP4/PI3K signaling activity and the malignant behavior of GC cells.CONCLUSION H.pylori induces JUN and FOSL1 expression to form AP-1,which transcriptionally activates DKK1.Binding of DKK1 to KAKP4 contributes to gastric tumorigenesis via the PI3K/AKT/mTOR pathway. 展开更多
关键词 Gastric cancer Helicobacter pylori Dickkopf-related protein 1 Cytoskeleton-associated protein 4 Phosphatidylinositol 3-kinase pathway
下载PDF
A clinical protocol: A double-blinded, randomized controlled trial on the effect of traditional Chinese medicine formula Shoutai Pill in the treatment of threatened abortion
3
作者 Li Li Jing-Yan Song +5 位作者 wen-xiu yang Cheng-Cheng Ji Yi-Ming Che Meng-Jie Wang Ying-Xin Wang Ning Zhang 《Clinical Research Communications》 2021年第3期1-6,共6页
for about 20%of all clinically confirmed pregnancy.It is the main cause of early abortion.Vaginal bleeding is the main clinical manifestation,which seriously affects the mental health and quality of life of pregnant w... for about 20%of all clinically confirmed pregnancy.It is the main cause of early abortion.Vaginal bleeding is the main clinical manifestation,which seriously affects the mental health and quality of life of pregnant women.Currently,there is effective treatment for this condition.A recent meta-analysis showed that Shoutai Pill(ST Pill),a traditional Chinese medicine(TCM)formula,can effectively decrease the rate of threatened abortion.However,high heterogeneity was found among the studies included in the meta-analysis,this conclusion on the efficacy of TCM is not definitive.Although several have been conducted,some of them do not describe randomization and blinding methods.To address these problems,this article proposes an improved clinical treatment scheme based on ST Pill,which is to be tested through a well-designed randomized controlled trial,for the treatment of threatened abortion.Methods:This is a double-blinded,randomized,placebo-controlled trial to be conducted in a public Three-A hospital in China's Mainland.A total of 200 people will be enrolled.Using computer-generated random numbers,the participants will be randomly divided into two groups at a ratio of 1:1(treatment group(treated with ST Pill group)and placebo group).Both groups will receive medication to the end of the 20th gestational week or 1 week after vaginal bleeding stops,depending on which is longer.Participants in the treatment group will be treated with ST Pill(20 pills/time,once a day),and those in the placebo group will receive a placebo drug which is similar in appearance and smell with ST Pill.The main observation index is the live birth rate.Discussion:Although the efficacy of ST Pill in threatened abortion is well-known,no study has tested its efficacy through a double-blinded,randomized trials.Therefore,there is an urgent need for a standardized randomized double-blinded controlled trial to evaluate the clinical efficacy of ST Pill.ST Pill is likely to be a convenient and effective TCM pill for the prevention of threatened abortion. 展开更多
关键词 Shoutai Pill threatened abortion traditional Chinese medicine randomized controlled trial
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部